Indian Patients with Diabetes Experienced Better Glycemic Control, Less Weight Gain and Hypoglycaemia with Insulin. Detemir When Switched from NPH and Insulin Glargine in PREDICTIVE™ Study

被引：0

作者：

Kesavadev, Jothydev

Singh, Parminder

Pitle, Shailesh Umakant

Bhttacharyya, Arpandev

Mayya, Raghavendra

Moharana, Ashok Kumar

Pathak, Ankit

Kalra, Sanjay

机构：

来源：

DIABETES | 2009年 / 58卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：A528 / A528

页数：1

共 50 条

[31] Insulin glargine maintains equivalent glycemic control and better lipometabolic control than NPH insulin in type 1 diabetes patients who missed a meal
Rosak, C.
Jung, R.
Hofmann, U.
HORMONE AND METABOLIC RESEARCH, 2008, 40 (08) : 544 - 548
[32] More subjects achieve an HbA1c ≤7% without hypoglycaemia or weight gain when treated with insulin detemir in comparison with NPH insulin
Hermansen, K.
Larsen, J.
Tamer, S. C.
Mathieu, C.
DIABETOLOGIA, 2007, 50 : S412 - S412
[33] Insulin detemir enables obese patients to improve glycemic control without weight gain
Selam, Jean-Louis
Koenen, Christoph
Merilainen, Markus
Meneghini, Luigi
DIABETES, 2007, 56 : A573 - A573
[34] Feasibility of improved glycemic control with insulin detemir and insulin glargine in combination with oral agents in insulin naive patients with type 2 diabetes
Rosenstock, J
Larsen, JJ
Draeger, E
Kristensen, HS
Davies, M
DIABETES, 2004, 53 : A145 - A145
[35] Initiating insulin detemir improves glycemic control without weight gain in OAD-treated insulin naive patients with type 2 diabetes:: Results from a German subgroup of the PREDICTIVE study
Dornhorst, Anne
Merilaeinen, Markus
Ratzmann, Klaus-Peter
DIABETES, 2006, 55 : A110 - A110
[36] Insulin detemir achieves lower, less variable fasting glucose and a reduced risk of nocturnal hypoglycaemia and weight gain compared to NPH insulin in basal bolus therapy of Japanese patients with type 1 diabetes
Kobayashi, M.
Iwamoto, Y.
Kawamori, R.
Tajima, N.
Nishida, T.
Kaku, K.
DIABETOLOGIA, 2006, 49 : 608 - 609
[37] Glycemic Control in Adult Type 1 Diabetes Patients with Insulin Glargine, Insulin Detemir, or Continuous Subcutaneous Insulin Infusion in Daily Practice
Rautiainen, Paivi
Tirkkonen, Hilkka
Laatikainen, Tiina
DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 (05) : 363 - 369
[38] Replacement of NPH Insulin with Insulin Glargine Provided Significantly Better Glycemic Control in Patients with Type 2 Diabetes Uncontrolled on NPH Plus Oral Antihyperglycemic Drugs or Short-Acting Insulin
Glinkina, Irina
Shestakova, Marina
DIABETES, 2011, 60 : A619 - A619
[39] Insulin detemir improves glycaemic control without weight gain in insulin-naive patients with type 2 diabetes:: subgroup analysis from the PREDICTIVE™ study
Dornhorst, A.
Lueddeke, H. -J.
Sreenan, S.
Kozlovski, P.
Hansen, J. B.
Looij, B. -J.
Meneghini, L.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2008, 62 (04) : 659 - 665
[40] A Comparison of Insulin Use, Glycemic Control, and Health Care Costs With Insulin Detemir and Insulin Glargine in Insulin-Naive Patients With Type 2 Diabetes
Borah, Bijan J.
Darkow, Theodore
Bouchard, Jonathan
Aagren, Mark
Forma, Felicia
Alemayehu, Berhanu
CLINICAL THERAPEUTICS, 2009, 31 (03) : 623 - 631

← 1 2 3 4 5 →